Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Dabigatran etexilate (Pradaxa®) is a new oral anticoagulant, competitive inhibitor, selective, fast, direct and reversible of thrombin. Dabigatran has an impact on a large panel of used coagulation tests. There is no relationship between thrombin time's lengthening and anti-IIa activity. This study defines thrombin time's predictive value, when its time is normal. The result of negative value is 97,6%. 255 patients were studied between January 2013 and July 2014. Thrombin time and anti-IIa activity were dosed for each patient. This study can be an assistant for therapeutic decision for laboratories without specialized test.


Maïlys Le Guyader, Mohammed Kaabar, Pierre Lemaire, Fabienne Pineau Vincent. Thrombin time and anti-IIa dabigatran's activity: hypothesis of thrombin time's predictive value. Annales de biologie clinique. 2015 Sep-Oct;73(5):544-6

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 26489812

View Full Text